Fun fact: all companies financed by Fife, Cytodyn’s toxic lender, have gone under. Crushing debt coupled with Infinite Dilution terms. Exactly the same thing for Cytodyn. More than 20 companies. P-value way better than Loserlimab!
Honest question deserves an honest answer. Pink sheets, no. But I never said anything other than building value. Alexion, with $5.9 billion of sales (which we can achieve} was bought out for $39 billion a year or two ago.I believe they were on the Nasdaq. And with multiple indications for our drug, with cancer being the real kicker and HIV giving us some revenue, I see no reason we couldn't have. a similar valuation.
Market Data 
Markets 
AI
